Singapore project focus shifting to clinical capability
This article was originally published in Scrip
Executive Summary
Singapore has set aside S$50 million ($32.9 million) in new funding to support studies on dengue fever and metabolic diseases, as part of a wider programme to build up local translational and clinical research (TCR) capabilities.